Biosimilar Interchangeability Switching Studies May Use Foreign Comparators, US FDA Says

 
• By Sue Sutter
bridge-completion
Building a bridge between foreign and US reference products might be more difficult for showing interchangeability than biosimilarity. • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics